Skip to Content

Efavirenz

In the US, Efavirenz (efavirenz systemic) is a member of the drug class NNRTIs and is used to treat HIV Infection, Nonoccupational Exposure and Occupational Exposure.

US matches:

UK matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

J05AG03

CAS registry number (Chemical Abstracts Service)

0154598-52-4

Chemical Formula

C14-H9-Cl-F3-N-O2

Molecular Weight

316

Therapeutic Categories

Antivirals for systemic use - Antiviral agent

Treatment of HIV infection

Non-nucleoside reverse transcriptase inhibitor (NNRTI)

Chemical Name

(S)-6-chloro-4-(cyclopropyletynyl)-1,4-dihydro-4-(trifluorometyl)-2H-3,1-benzoxazin-2-one (WHO, Ph. Int.)

Foreign Names

  • Efavirenzum (Latin)
  • Efavirenz (German)
  • Éfavirenz (French)
  • Efavirenz (Spanish)

Generic Names

  • Efavirenz (OS: BAN, JAN)
  • Éfavirenz (OS: DCF)
  • DMP 266 (DuPont Merck) (IS)
  • L 743726 (DuPont Merck) (IS)
  • Efavirenz (PH: Ph. Int. 7, USP 41)
  • Efavirenzum (PH: Ph. Int. 7)

Brand Names

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Hide